Skip to main content
Log in

Endothelial cells, nitric oxide and ischaemic preconditioning

  • Focussed Issue: Ischemic Preconditioning
  • Triggers and Mediators of Ischemic Preconditioning: Adenosine, Bradykhinin, Nitric Oxide and KATP-Chamels
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Parratt JR, Vegh A (1994) Pronounced antiarrhythmic effects of ischemic preconditioning. Cardioscience 5: 9–18

    Google Scholar 

  2. Vegh A, Komori S, Szekeres L, Parratt JR (1992) Antiarrhythmic effect of preconditioning in anaesthetised dogs and rats. Cardiovasc Res 26: 487–495

    Google Scholar 

  3. Piacentini L, Wainwright CL, Parratt JR (1993) The antiarrhythmic effect of ischaemic preconditioning in rat isolated hearts involves a pertussis toxin sensitive mechanism. Cardiovasc Res 27: 674–680

    Google Scholar 

  4. Vegh A, Papp JGy, Parratt JR (1994) Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br J Pharmacol 113: 1081–1082

    Google Scholar 

  5. Coker SJ, Parratt JR, Ledingham IMcL, Zeitlin IJ (1981) Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature 291: 323–324

    Google Scholar 

  6. Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Tada M, Inoue M, Hori M, Kamada T (1995) Plasma nitric oxide end products are increased in the ischemic canine heart. Biochem Biophys Res Commun 211: 370–374

    Google Scholar 

  7. Vegh A, Szekeres L, Parratt JR (1992) Preconditioning of the ischaemic myocardium; involvement of the Larginine nitric oxide pathway. Br J Pharmacol 107: 648–652

    Google Scholar 

  8. Vegh A, Papp JGy, Parratt JR (1994) Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors. Br J Pharmacol 113: 1167–1172

    Google Scholar 

  9. Vegh A, Kaszala K, Papp JGy, Parratt JR (1995) Delayed myocardial protection by pacing-induced preconditioning; a possible role for bradykinin. Br J Pharmacol (in press)

  10. Vegh A, Szekeres L, Parratt JR (1990) Protective effects of preconditioning on the ischaemic myocardium involves cyclo-oxygenase products. Cardiovasc Res 24: 1020–1022

    Google Scholar 

  11. Kis A, Vegh A, Papp JGy, Parratt JR (1995) Dual blockade of the cyclooxygenase and L-arginine-nitric oxide pathways prevents the antiarrhythmic effects of preconditioning. J Molec Cell Cardiol 27: A159

    Google Scholar 

  12. Szilvassy Z, Jakab I, Lonovics J, Papp JGy (1992) Is rapid pacing-induced preconditioning related to changes of myocardial cyclic nucleotide content? J Mol Cell Cardiol 24 (Supp V): S99

    Google Scholar 

  13. Parratt JR (1995) Possibilities for the pharmacological exploitation of ischaemic preconditioning. J Mol Cell Cardiol 27: 991–1000

    Google Scholar 

  14. Wu Song, Furman BL, Parratt JR (1994) Endotoxin protection against ischaemiainduced ventricular arrhythmias is attenuated by dexamethasone. Br J Pharmac 113: 1083–1084

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parratt, J.R., Vegh, A. Endothelial cells, nitric oxide and ischaemic preconditioning. Basic Res Cardiol 91, 27–30 (1996). https://doi.org/10.1007/BF00788857

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00788857

Key words

Navigation